1. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011; 43:1–11.
2. Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY, Ryu JS, et al. National survey of lung cancer in Korea, 2005. J Lung Cancer. 2007; 6:67–73.
3. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007; 2:706–714.
4. Jung SY, Park DI, Park MR, Jung SS, Kim JO, Kim SY, et al. Clinical characteristics of patients older than 76 with lung cancer. Korean J Med. 2012; 82:562–568.
5. Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi F, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst. 2003; 95:362–372.
6. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol. 2003; 21:3201–3206.
7. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol. 1982; 77:123–136.
8. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62:10–29.
9. Kim HS, Hyun DS, Kim KC, Lee SC, Jung TH, Park JY, et al. The clinical characteristics and prognosis of elderly patient with lung cancer diagnosed in Daegu and Gyeongsangbukdo. Tuberc Respir Dis. 2008; 65:15–22.
10. Hsu CL, Chen KY, Shih JY, Ho CC, Yang CH, Yu CJ, et al. Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer. 2012; 12:241.
11. Jang TW, Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY, et al. Female lung cancer: re-analysis of national survey of lung cancer in Korea, 2005. J Lung Cancer. 2010; 9:57–63.
12. Berghmans T, Paesmans M, Sculier JP. Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol. 2011; 3:127–138.
13. Rivera MP, Stover DE. Gender and lung cancer. Clin Chest Med. 2004; 25:391–400.
14. Brown JS, Eraut D, Trask C, Davison AG. Age and the treatment of lung cancer. Thorax. 1996; 51:564–568.
15. Montella M, Gridelli C, Crispo A, Scognamiglio F, Ruffolo P, Gatani T, et al. Has lung cancer in the elderly different characteristics at presentation? Oncol Rep. 2002; 9:1093–1096.
16. Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005; 9:Suppl 2. S51–S63.
17. Yang R, Cheung MC, Pedroso FE, Byrne MM, Koniaris LG, Zimmers TA. Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res. 2011; 170:e75–e83.
18. Luo J, Chen YJ, Narsavage GL, Ducatman A. Predictors of survival in patients with non-small cell lung cancer. Oncol Nurs Forum. 2012; 39:609–616.
19. Langer CJ. Clinical evidence on the undertreatment of older and poor performance patients who have advanced non-small-cell lung cancer: is there a role for targeted therapy in these cohorts? Clin Lung Cancer. 2011; 12:272–279.